Back to Interventions
Substance / Medication

Betamethasone acetate

SNOMED 116572001UMLS C0005310

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Psoriasis
Atopic dermatitis
Pruritus ani
Atopic neurodermatitis
Dermatosis of scalp

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Eosinophils

LOINC 711-2

primary

IgE

LOINC 19113-0

primary

Clinical Trials

145 trials linked to this intervention

145
Total Trials
25
Recruiting
61
With Results

Recent Trials

A Study to Evaluate Raptiva in Combination With Topical Psoriasis Therapies

NCT00096980Phase 4Completed300 enrolled

Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of Psoriasis

NCT00110981Phase 4Completed86 enrolled

Enbrel® in Psoriatic Arthritis

NCT00111124Phase 4Completed

Study Evaluating Etanercept and Methotrexate in Plaque Psoriasis

NCT00161655Phase 4Completed60 enrolled

Study Evaluating Etanercept in the Treatment of Subjects With Psoriasis

NCT00195507Phase 4Completed720 enrolled
View all 145 trials on ClinicalTrials.gov

Research Evidence

Published studies and systematic reviews

Sort:
Effects of preoperative doses of betamethasone acetate 0.1% on dry eye control after cataract surgery.
Shokoohi-Rad Saeed, Javaheri Seyedeh Zeinab Hashemi, Malekabad Fatemeh Zare et al. · Indian J Ophthalmol · 2020
PMID: 32057000RCTFull text (PMC)
Pharmacokinetics of intra-articular betamethasone sodium phosphate and betamethasone acetate and endogenous hydrocortisone suppression in exercising horses.
Menendez M I, Phelps M A, Bertone A L · J Vet Pharmacol Ther · 2016
PMID: 25847081RCT
Impact of a terbinafine-florfenicol-betamethasone acetate otic gel on the quality of life of dogs with acute otitis externa and their owners.
Noli Chiara, Sartori Roberta, Cena Tiziana · Vet Dermatol · 2017
PMID: 28295766Observational
A fast, validated UPLC method coupled with PDA-QDa detectors for impurity profiling in betamethasone acetate and betamethasone phosphate injectable suspension and isolation, identification, characterization of two thermal impurities.
Murali Krishnam Raju P, Shyamala P, Venkata Narayana B et al. · Ann Pharm Fr · 2022
PMID: 35489418Other
Annoying Hiccups following Intra-Articular Corticosteroid Injection of Betamethasone Acetate/Betamethasone Sodium Phosphate at the Knee Joint.
Habib George, Artul Suheil, Hakim Geries · Case Rep Rheumatol · 2013
PMID: 23573452OtherFull text (PMC)
The effect of intra-articular injection of betamethasone acetate/betamethasone sodium phosphate at the knee joint on the hypothalamic-pituitary-adrenal axis: a case-controlled study.
Habib George, Artul Suheil, Chernin Mark et al. · J Investig Med · 2013
PMID: 24013525Other
The effect of intra-articular injection of betamethasone acetate/betamethasone sodium phosphate on blood glucose levels in controlled diabetic patients with symptomatic osteoarthritis of the knee.
Habib George, Safia Ahmed · Clin Rheumatol · 2009
PMID: 18853221Other
Betamethasone phosphate reduces the efficacy of antenatal steroid therapy and is associated with lower birthweights when administered to pregnant sheep in combination with betamethasone acetate.
Takahashi Tsukasa, Fee Erin L, Takahashi Yuki et al. · Am J Obstet Gynecol · 2022
PMID: 34626553Preclinical
Impact of synthetic canine cerumen on in vitro penetration of auricular skin of dogs by florfenicol, terbinafine, and betamethasone acetate.
Ehling Sarah, Baynes Ronald E, Bäumer Wolfgang · Am J Vet Res · 2018
PMID: 29466046Preclinical
Pharmacokinetics of betamethasone after single-dose intramuscular administration of betamethasone phosphate and betamethasone acetate to healthy subjects.
Salem Isam I, Najib Naji M · Clin Ther · 2012
PMID: 22154197Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Specialists

Providers who commonly manage this intervention

Dermatology Physician

Dermatology

NUCC 207N00000X
Allergy & Immunology (Internal Medicine) Physician

Internal Medicine — Allergy & Immunology

NUCC 207RA0201X
Find a Provider

Health Goals

Goals connected through associated conditions

Promote Skin Health

Quick Facts

Type
Substance / Medication
Fully Specified Name
Betamethasone acetate (substance)
SNOMED CT
116572001
UMLS CUI
C0005310

Clinical Data

This intervention maps to 10 entities in the Healos knowledge graph.

5
Conditions
2
Biomarkers
2
Specialists
0
Symptoms
145
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.